Cerebrospinal fluid neurotransmitter changes during the perioperative period in patients undergoing total knee replacement: A randomized trial

Anesthesia and Analgesia

Volumn 114, Issue 2, 2012, Pages 434-441

  Buvanendran, Asokumar ^a   Kroin, Jeffrey S ^a   Della Valle, Craig J ^a   Moric, Mario ^a   Tuman, Kenneth J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; GLUTAMIC ACID; NORADRENALIN; PLACEBO; PREGABALIN; SUBSTANCE P;

AGED; ANALGESIC ACTIVITY; ARTICLE; CATHETER; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG USE; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; LUMBAR SPINE; MALE; NEEDLE; NORADRENALIN BRAIN LEVEL; PAIN ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SHORT FORM 36; SINGLE DRUG DOSE; SPINAL ANESTHESIA; TOTAL KNEE REPLACEMENT;

AGED; ANALGESIA; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS; ARTHROPLASTY, REPLACEMENT, KNEE; CALCITONIN GENE-RELATED PEPTIDE; CHICAGO; DRUG ADMINISTRATION SCHEDULE; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PERIOPERATIVE PERIOD; PROSPECTIVE STUDIES; SPINAL PUNCTURE; SUBSTANCE P; TIME FACTORS; TREATMENT OUTCOME;

EID: 84856223938     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31823dc5fb     Document Type: Article

References (30)

1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007;89:780-5
2. Harden RN, Bruehl S, Stanos S, Brander V, Chung OY, Saltz S, Adams A, Stulberg SD. Prospective examination of painrelated and psychological predictors of CRPS-like phenomena following total knee arthroplasty: a preliminary study. Pain 2003;106:393-400 (Pubitemid 37505887)
3. BuVanendran A, Kroin JS, Della Valle CJ, Kari M, Moric M, Tuman KJ. Pregabalin reduces chronic pain and improves range of motion after total knee arthroplasty: a prospective, randomized trial. Anesth Analg 2010;110:199-207
4. Sjö ström S, Tamsen A, Hartvig P, Folkesson R, Terenius L. Cerebrospinal fluid concentrations of substance P and (met)enkephalin-Arg6-Phe7 during surgery and patientcontrolled analgesia. Anesth Analg 1988;67:976-81
5. Oehkme MJ, Podranski T, Mann M, Frickey N, Kuhn DF, Hempelmann G. Perioperative concentrations of catecholamines in the cerebrospinal fluid and plasma during spinal anesthesia. Acta Anaesthesiol Scand 2008;52:487-92 (Pubitemid 351392850)
6. Yaksh TL. Spinal systems and pain processing: development of novel analgesic drugs with mechanistically defined models. Trends Pharmacol Sci 1999;20:329-37 (Pubitemid 29366811)
7. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009;10:895-926
8. Hayashida K, DeGoes S, Curry R, Eisenach JC. Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. Anesthesiology 2007; 106:557-62 (Pubitemid 46662222)
9. Field MJ, Holloman EF, McCleary S, Hughes J, Singh L. Evaluation of gabapentin and S-(-)-3-isobutylgaba in a rat model of postoperative pain. J Pharmacol Exp Ther 1997; 282:1242-6 (Pubitemid 27408300)
10. Zahn PK, Sluka KA, Brennan TJ. Excitatory amino acid release in the spinal cord caused by plantar incision in the rat. Pain 2002;100:65-76 (Pubitemid 35305124)
11. Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 2003;105:133-41 (Pubitemid 37162482)
12. Cunningham MO, Woodhall GL, Thompson SE, Dooley DJ, Jones RS. Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. Eur J Neurosci 2004;20:1566-76 (Pubitemid 39294695)
13. Brawek B, Löffler M, Dooley DJ, Weyerbrock A, Feuerstein TJ. Differential modulation of K(-)-evoked (3)H-neurotransmitter release from human neocortex by gabapentin and pregabalin. Naunyn Schmiedebergs Arch Pharmacol 2008;376:301-7
14. BuVanednran A, Kroin JS, Kari M, Tuman KJ. Can a single dose of 300 mg pregabalin reach acute anti-hyperalgesic levels in the central nervous system? Reg Anesth Pain Med 2010;35:535-8
15. BuVanendran A, Kroin JS, Tuman KJ, Lubenow TR, Elmofty D, Moric M, Rosenberg AG. Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement. JAMA 2003;290:2411-8 (Pubitemid 37430540)
16. BuVanendran A, Kroin JS, Berger RA, Kroin JS, Berger RA, Hallab NJ, Saha C, Negrescu C, Moric M, Caicedo MS, Tuman KJ. Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology 2006;104:403-10
17. Sethuraman R, Lee TL, Chui JW, Tachibana S. Changes in amino acids and nitric oxide concentration in cerebrospinal fluid during labor pain. Neurochem Res 2006;31:1127-33 (Pubitemid 44379673)
18. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York: Academic Press, 1988
19. Eisenach JC, Hood DD, Tuttle R, Shafer S, Smith T, Tong C. Computer-controlled epidural infusion to targeted cerebrospinal fluid concentrations in humans: clonidine. Anesthesiology 1995;83:33-47
20. Lindh C, Liu Z, Lyrenäs S, Ordeberg G, Nyberg F. Elevated cerebrospinal fluid substance P-like immunoreactivity in patients with painful osteoarthritis, but not in patients with rhizopatic pain from a herniated lumbar disc. Scand J Rheumatol 1997;26:468-72 (Pubitemid 28005052)
21. Lindh C, Liu Z, Welin M, Ordeberg G, Nyberg F. Low calcitonin gene-related, peptide-like immunoreactivity in cerebrospinal fluid from chronic pain patients. Neuropeptides 1999;33:517-21 (Pubitemid 30110885)
22. Alfredsson G, Wiesel FA, Tylec A. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers. Biol Psychiatry 1988; 23:689-97 (Pubitemid 18086648)
23. Eisenach JC, Detweiler DJ, Tong C, D'Angelo R, Hood DD. Cerebrospinal fluid norepinephrine and acetylcholine concentrations during acute pain. Anesth Analg 1996;82:621-6 (Pubitemid 26072972)
24. Larson AA, Giovengo SL, Russell IJ, Michalek JE. Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain 2000;87:201-11 (Pubitemid 30621452)
25. Yu LC, Hou JF, Fu FH, Zhang YX. Roles of calcitonin generelated peptide and its receptors in pain-related behavioral responses in the central nervous system. Neurosci Biobehav Rev 2009;33:1185-91
26. Kew JN, Kemp JA. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl) 2005;179:4-29 (Pubitemid 40576690)
27. Ossipov MH, Lai J, King T, Vanderah TW, Malan TP Jr, Hruby VJ, Porreca F. Antinociceptive and nociceptive actions of opioids. J Neurobiol 2004;61:126-48 (Pubitemid 39287774)
28. Di Chiro GD, Hammock MK, Bleyer WA. Spinal descent of cerebrospinal fluid in man. Neurology 1976;26:1-8
29. Kroin JS, Ali A, York M, Penn RD. The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery 1993;33:226-30 (Pubitemid 23230581)
30. Jones SL. Descending noradrenergic influences on pain. Prog Brain Res 1991;88:381-94